Glaxosmithkline and Elbion to Collaborate on Development and Commercialisation of a new DE IV Inhibitor
25-Jan-2005
Most read news
Topics
inhibitors
GlaxoSmithKline
Elbion
pulmonary diseases
phase I studies
GSK
clinical trials
asthma
allergic rhinitis
Organizations
GSK
Elbion
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.